Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

about

Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances.Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis.

P2860

Q39292937-2FB15E3E-9C0A-4DD8-A44F-E481010B19A5 Q47388012-511A5C08-ACB2-43FC-84FF-895C7E2BD197

P2860

Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

Item

http://www.wikidata.org/entity/Q36040552

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Rebamipide does not protect ag ...... double-blind controlled trial.

@ast

Rebamipide does not protect ag ...... double-blind controlled trial.

@en

type

Item

label

Rebamipide does not protect ag ...... double-blind controlled trial.

@ast

Rebamipide does not protect ag ...... double-blind controlled trial.

@en

prefLabel

Rebamipide does not protect ag ...... double-blind controlled trial.

@ast

Rebamipide does not protect ag ...... double-blind controlled trial.

@en

P1476

Rebamipide does not protect ag ...... double-blind controlled trial.

@en

P2093

Aloísio Carvalhaes

http://www.w3.org/2001/XMLSchema#string

Antônio Frederico N Magalhães

http://www.w3.org/2001/XMLSchema#string

John L Wallace

http://www.w3.org/2001/XMLSchema#string

Miriam S Trevisan

http://www.w3.org/2001/XMLSchema#string

Ronilson A Moreno

http://www.w3.org/2001/XMLSchema#string

P2860

The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events

Prostaglandin E2 content in residual gastric juice reflects endoscopic damage to the gastric mucosa after naproxen sodium administration.

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity

Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms.

Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.

Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.

Assessment of gastric acidity of Japanese subjects over the last 15 years.

Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.

P2888

s12876-016-0472-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12876-016-0472-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017084646

http://www.w3.org/2001/XMLSchema#string

P698

27259970

http://www.w3.org/2001/XMLSchema#string

P932

4893238

http://www.w3.org/2001/XMLSchema#string

Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

about

P2860

P2860

Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932